Language

Target groups›Pharmaceutical wholesale distributors›Supplier & customer qualification

Service area · Wholesale distribution of medicinal products

Qualify pharmaceutical suppliers and customers under GDP

Last updated: 27 August 2026

Verify, approve and monitor authorised medicine suppliers, customers, delivery addresses and critical service providers.

Design partner qualification →
Supplier and customer qualification in pharmaceutical wholesale

GDP supply chain · due diligence · monitoring

Supplier and customer qualification in pharmaceutical wholesale

Verify, approve and monitor authorised medicine suppliers, customers, delivery addresses and critical service providers.

A controlled supply chain needs more than a certificate on file. We connect register checks, scope verification, risk assessment, quality agreements and blocking rules.

Expert-reviewed by Martin Didunyk · licensed pharmacist · 27 August 2026

tiger.PHARMA Expertise

Topics we master

Qualify suppliers before purchase

Qualify suppliers before purchase

Manufacturers, importers and wholesalers are checked against product, activity, location and supply route.

  • Verify identity and legal entity
  • Check manufacturing or wholesale authorisation
  • Match site and authorised scope
  • Document approval before first receipt
Verify customers and delivery addresses

Verify customers and delivery addresses

Recipient eligibility must match the product, activity and actual delivery point.

  • Classify pharmacy, wholesaler or other recipient
  • Verify licence and registered site
  • Control alternative delivery addresses
  • Reassess changes before delivery
Licences, certificates and registers

Licences, certificates and registers

Register results are interpreted for scope, status, site and date; one document alone is not sufficient.

  • Use EudraGMDP and national registers
  • Monitor expiry and status changes
  • Identify diversion or falsification signals
  • Retain review evidence
Risk, audit and ongoing monitoring

Risk, audit and ongoing monitoring

Criticality and performance determine audit frequency, agreements and review cycles.

  • Risk class and requalification cycle
  • Quality or technical agreement
  • KPI, complaint and deviation monitoring
  • Blocking and escalation workflow
Assign GDP findings to the Responsible Person and the operating team

Assign GDP findings to the Responsible Person and the operating team

Audit findings and partner decisions need a defined owner and escalation route. Review which actions sit with operations, management or the Responsible Person. Where external Responsible Person support is being considered for German wholesale, agree duties, access to records and availability before the mandate starts.

Define suitability, responsibilities, cooperation and coverage. External Responsible Person for German pharmaceutical wholesale →

    FAQ

    Frequently asked questions

    How is a pharmaceutical supplier qualified?

    Verify identity, site, activity, authorisation and GDP status using reliable registers and evidence, then document risk assessment, approval and periodic monitoring.

    Must every wholesale customer be qualified?

    The wholesaler must verify that the recipient is entitled to receive the relevant medicines before supply. The depth and review cycle are risk-based.

    Is a GDP certificate enough for approval?

    No. Its issuer, site, scope and status must be assessed together with authorisation and supply-chain information.

    © 2026 tiger.PHARMA